adplus-dvertising
Connect with us

News

Rising cases 'frightening,' PM Trudeau says, vows vaccine rollout will 'scale up' – CTV News

Published

 on


OTTAWA —
Prime Minister Justin Trudeau says the state of the pandemic is “frightening,” and is vowing that the number of Pfizer-BioNTech and Moderna vaccines being delivered to Canada will “scale up,” in February.

In a national address on Friday, the prime minister said that 68 delivery sites across the country received thousands of Pfizer and Moderna doses this week. In light of provincial calls for more doses, he said quantities of both will continue to increase.

“Quantities of both the Pfizer and the Moderna vaccine will scale up in February. Remember that Canada has the most vaccines secured per capita in the world, which means that, by September, we will have enough vaccines for every Canadian who wants one,” he said during his national update on the COVID-19 response on Friday. 

As the rollout plan stands over the rest of January, Canada will receive 208,650 Pfizer doses per week. In February Canada will receive approximately 367,000 doses of the Pfizer vaccine per week, before hitting a total of four million shots distributed by the end of March.

The next batch of Moderna doses—which are being delivered every three weeks—will arrive next week and include 171,000 doses, as will the first February shipment. Delivery amounts will then be increasing to up to 250,000 doses weekly in order to hit the planned two million Moderna doses distributed by the end of March.

“As our collective understanding of these new vaccines evolves and the manufacturer updates their product monographs and instructions, we are able to adapt, how and where we distribute and administer vaccines to Canadians,” said Fortin.

For example, he said Pfizer has updated its guidelines in the last week to administer doses in a thawed state and in smaller tray sizes, meaning the vaccines can be transported and administered to more sites across Canada.

Facing questions about the coming dose delivery schedule and whether larger shipments of these two vaccines is possible, Procurement Minister Anita Anand said she’s continuing talks with the manufacturers about accelerating shipments. 

Though, as the lead of Canada’s national rollout said, Canada’s vaccination strategy is deliberately phased. 

“This initial phase, or phase one, is characterized by limited and steady supply of vaccines for much of January, February, and March before we see a significant ramp up leading into April and the rest of the second quarter of the year,” said Maj. Gen. Dany Fortin on Friday. 

“A total of six million doses are expected to be distributed by end of March,” he said. 

In a statement, Conservative health critic Michelle Rempel Garner called on Trudeau to procure additional vaccines. 

“Canadian provinces are running out of vaccines and are pleading for the federal government to get more. Meanwhile, people in Israel are getting their vaccines ten times faster than Canadians. The United States is on track to vaccinate the equivalent of our population before most Canadians will get the chance. But Canada only has a federal Liberal government finger-pointing on who is responsible for a slow vaccine delivery rollout,” she said. 

“It doesn’t matter how many doses the federal Liberals supposedly ordered; the reality is that they’re not here now.” 

As for whether Canada could still hit the September target for all Canadians receiving the vaccine, Anand said Health Canada approval of an additional vaccine would be required to receive the total number of doses necessary to immunize the entire population, though the majority of vaccines given to Canadians will likely be one of the two shots currently approved.

The next two vaccines in line for potential Health Canada sign-off are the AstraZeneca and Johnson & Johnson candidates. Health Canada Senior Medical Advisor Dr. Supriya Sharma said Friday that the agency is expecting additional clinical and manufacturing information from both studies in the coming weeks, but so far the reviews are progressing “well.” 

As Canada’s contracts with these pharmaceutical companies stand, Canada has secured access to up to 76 million doses of the Pfizer vaccine; up to 40 million doses of the Moderna vaccine; up to 20 million doses of the AstraZeneca vaccine candidate; and up to 38 million doses of the Johnson & Johnson vaccine candidate. 

On Thursday night Trudeau held a call with his provincial and territorial counterparts about the pace of the vaccine rollout. After calling for premiers to get on with it, provinces and their health care facilities have accelerated their administration of immunizations and are now calling for larger deliveries of doses from the federal government, more quickly.

Addressing the comments from some provincial officials—including those at Ontario’s University Health Network—who have said they are running out of vaccine doses with hundreds of health-care workers slated to receive shots in the coming days, Anand suggested they use the figures released on Friday to plan accordingly. 

“That schedule is in existence, it has been shared with the public, and the provinces, and the planning should take place on the basis of that schedule,” she said. 

“Our numbers are their numbers,” added Fortin. 

During Trudeau’s cross-Canada call with the premiers, the political leaders also discussed the continued rise in COVID-19 cases and increasing outbreaks in long-term care homes. 

COVID-19 INFECTION RATE ‘FRIGHTENING’ 

The prime minister’s latest update from Rideau Cottage comes as one of Ontario’s top public health officials is warning the pandemic curve is going “the wrong way.”

“Today’s numbers are to be frank, they are scary… It’s going the wrong way,” Ontario’s Associate Chief Medical Officer of Health Dr. Barbara Yaffe said Friday morning. “We have more and more people hospitalized, more and more people in ICU, more and more people on ventilators.”

Across the country, with many focused on the vaccine administration figures, the number of COVID-19 cases and deaths are climbing following the holiday season, despite varying degrees of lockdowns across Canada.

“We’re in a desperate situation,” Ontario Premier Doug Ford said Friday of the situation in his province. “This is the most serious situation we’ve ever been in… since the beginning of this pandemic.” 

There are more than 80,000 active cases across the country, and there have been a total of 639,3833 confirmed COVID-19 infections since the start of the pandemic. More than 16,500 people have died.

“Frankly, it’s frightening to see cases rise at home and around the world, day after day,” Trudeau said.

Acknowledging the state of the pandemic, the prime minister said he knows things are “tough” right now, imploring people to take the necessary public health measures and committing to keep up federal aid from economic supports to the deployment of the military to assist in communities facing outbreaks. 

Let’s block ads! (Why?)

728x90x4

Source link

Continue Reading

News

STD epidemic slows as new syphilis and gonorrhea cases fall in US

Published

 on

 

NEW YORK (AP) — The U.S. syphilis epidemic slowed dramatically last year, gonorrhea cases fell and chlamydia cases remained below prepandemic levels, according to federal data released Tuesday.

The numbers represented some good news about sexually transmitted diseases, which experienced some alarming increases in past years due to declining condom use, inadequate sex education, and reduced testing and treatment when the COVID-19 pandemic hit.

Last year, cases of the most infectious stages of syphilis fell 10% from the year before — the first substantial decline in more than two decades. Gonorrhea cases dropped 7%, marking a second straight year of decline and bringing the number below what it was in 2019.

“I’m encouraged, and it’s been a long time since I felt that way” about the nation’s epidemic of sexually transmitted infections, said the CDC’s Dr. Jonathan Mermin. “Something is working.”

More than 2.4 million cases of syphilis, gonorrhea and chlamydia were diagnosed and reported last year — 1.6 million cases of chlamydia, 600,000 of gonorrhea, and more than 209,000 of syphilis.

Syphilis is a particular concern. For centuries, it was a common but feared infection that could deform the body and end in death. New cases plummeted in the U.S. starting in the 1940s when infection-fighting antibiotics became widely available, and they trended down for a half century after that. By 2002, however, cases began rising again, with men who have sex with other men being disproportionately affected.

The new report found cases of syphilis in their early, most infectious stages dropped 13% among gay and bisexual men. It was the first such drop since the agency began reporting data for that group in the mid-2000s.

However, there was a 12% increase in the rate of cases of unknown- or later-stage syphilis — a reflection of people infected years ago.

Cases of syphilis in newborns, passed on from infected mothers, also rose. There were nearly 4,000 cases, including 279 stillbirths and infant deaths.

“This means pregnant women are not being tested often enough,” said Dr. Jeffrey Klausner, a professor of medicine at the University of Southern California.

What caused some of the STD trends to improve? Several experts say one contributor is the growing use of an antibiotic as a “morning-after pill.” Studies have shown that taking doxycycline within 72 hours of unprotected sex cuts the risk of developing syphilis, gonorrhea and chlamydia.

In June, the CDC started recommending doxycycline as a morning-after pill, specifically for gay and bisexual men and transgender women who recently had an STD diagnosis. But health departments and organizations in some cities had been giving the pills to people for a couple years.

Some experts believe that the 2022 mpox outbreak — which mainly hit gay and bisexual men — may have had a lingering effect on sexual behavior in 2023, or at least on people’s willingness to get tested when strange sores appeared.

Another factor may have been an increase in the number of health workers testing people for infections, doing contact tracing and connecting people to treatment. Congress gave $1.2 billion to expand the workforce over five years, including $600 million to states, cities and territories that get STD prevention funding from CDC.

Last year had the “most activity with that funding throughout the U.S.,” said David Harvey, executive director of the National Coalition of STD Directors.

However, Congress ended the funds early as a part of last year’s debt ceiling deal, cutting off $400 million. Some people already have lost their jobs, said a spokeswoman for Harvey’s organization.

Still, Harvey said he had reasons for optimism, including the growing use of doxycycline and a push for at-home STD test kits.

Also, there are reasons to think the next presidential administration could get behind STD prevention. In 2019, then-President Donald Trump announced a campaign to “eliminate” the U.S. HIV epidemic by 2030. (Federal health officials later clarified that the actual goal was a huge reduction in new infections — fewer than 3,000 a year.)

There were nearly 32,000 new HIV infections in 2022, the CDC estimates. But a boost in public health funding for HIV could also also help bring down other sexually transmitted infections, experts said.

“When the government puts in resources, puts in money, we see declines in STDs,” Klausner said.

___

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group. The AP is solely responsible for all content.

Source link

Continue Reading

News

World’s largest active volcano Mauna Loa showed telltale warning signs before erupting in 2022

Published

 on

 

WASHINGTON (AP) — Scientists can’t know precisely when a volcano is about to erupt, but they can sometimes pick up telltale signs.

That happened two years ago with the world’s largest active volcano. About two months before Mauna Loa spewed rivers of glowing orange molten lava, geologists detected small earthquakes nearby and other signs, and they warned residents on Hawaii‘s Big Island.

Now a study of the volcano’s lava confirms their timeline for when the molten rock below was on the move.

“Volcanoes are tricky because we don’t get to watch directly what’s happening inside – we have to look for other signs,” said Erik Klemetti Gonzalez, a volcano expert at Denison University, who was not involved in the study.

Upswelling ground and increased earthquake activity near the volcano resulted from magma rising from lower levels of Earth’s crust to fill chambers beneath the volcano, said Kendra Lynn, a research geologist at the Hawaiian Volcano Observatory and co-author of a new study in Nature Communications.

When pressure was high enough, the magma broke through brittle surface rock and became lava – and the eruption began in late November 2022. Later, researchers collected samples of volcanic rock for analysis.

The chemical makeup of certain crystals within the lava indicated that around 70 days before the eruption, large quantities of molten rock had moved from around 1.9 miles (3 kilometers) to 3 miles (5 kilometers) under the summit to a mile (2 kilometers) or less beneath, the study found. This matched the timeline the geologists had observed with other signs.

The last time Mauna Loa erupted was in 1984. Most of the U.S. volcanoes that scientists consider to be active are found in Hawaii, Alaska and the West Coast.

Worldwide, around 585 volcanoes are considered active.

Scientists can’t predict eruptions, but they can make a “forecast,” said Ben Andrews, who heads the global volcano program at the Smithsonian Institution and who was not involved in the study.

Andrews compared volcano forecasts to weather forecasts – informed “probabilities” that an event will occur. And better data about the past behavior of specific volcanos can help researchers finetune forecasts of future activity, experts say.

(asterisk)We can look for similar patterns in the future and expect that there’s a higher probability of conditions for an eruption happening,” said Klemetti Gonzalez.

___

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group. The AP is solely responsible for all content.

The Canadian Press. All rights reserved.

Source link

Continue Reading

News

Waymo’s robotaxis now open to anyone who wants a driverless ride in Los Angeles

Published

 on

 

Waymo on Tuesday opened its robotaxi service to anyone who wants a ride around Los Angeles, marking another milestone in the evolution of self-driving car technology since the company began as a secret project at Google 15 years ago.

The expansion comes eight months after Waymo began offering rides in Los Angeles to a limited group of passengers chosen from a waiting list that had ballooned to more than 300,000 people. Now, anyone with the Waymo One smartphone app will be able to request a ride around an 80-square-mile (129-square-kilometer) territory spanning the second largest U.S. city.

After Waymo received approval from California regulators to charge for rides 15 months ago, the company initially chose to launch its operations in San Francisco before offering a limited service in Los Angeles.

Before deciding to compete against conventional ride-hailing pioneers Uber and Lyft in California, Waymo unleashed its robotaxis in Phoenix in 2020 and has been steadily extending the reach of its service in that Arizona city ever since.

Driverless rides are proving to be more than just a novelty. Waymo says it now transports more than 50,000 weekly passengers in its robotaxis, a volume of business numbers that helped the company recently raise $5.6 billion from its corporate parent Alphabet and a list of other investors that included venture capital firm Andreesen Horowitz and financial management firm T. Rowe Price.

“Our service has matured quickly and our riders are embracing the many benefits of fully autonomous driving,” Waymo co-CEO Tekedra Mawakana said in a blog post.

Despite its inroads, Waymo is still believed to be losing money. Although Alphabet doesn’t disclose Waymo’s financial results, the robotaxi is a major part of an “Other Bets” division that had suffered an operating loss of $3.3 billion through the first nine months of this year, down from a setback of $4.2 billion at the same time last year.

But Waymo has come a long way since Google began working on self-driving cars in 2009 as part of project “Chauffeur.” Since its 2016 spinoff from Google, Waymo has established itself as the clear leader in a robotaxi industry that’s getting more congested.

Electric auto pioneer Tesla is aiming to launch a rival “Cybercab” service by 2026, although its CEO Elon Musk said he hopes the company can get the required regulatory clearances to operate in Texas and California by next year.

Tesla’s projected timeline for competing against Waymo has been met with skepticism because Musk has made unfulfilled promises about the company’s self-driving car technology for nearly a decade.

Meanwhile, Waymo’s robotaxis have driven more than 20 million fully autonomous miles and provided more than 2 million rides to passengers without encountering a serious accident that resulted in its operations being sidelined.

That safety record is a stark contrast to one of its early rivals, Cruise, a robotaxi service owned by General Motors. Cruise’s California license was suspended last year after one of its driverless cars in San Francisco dragged a jaywalking pedestrian who had been struck by a different car driven by a human.

Cruise is now trying to rebound by joining forces with Uber to make some of its services available next year in U.S. cities that still haven’t been announced. But Waymo also has forged a similar alliance with Uber to dispatch its robotaxi in Atlanta and Austin, Texas next year.

Another robotaxi service, Amazon’s Zoox, is hoping to begin offering driverless rides to the general public in Las Vegas at some point next year before also launching in San Francisco.

The Canadian Press. All rights reserved.

Source link

Continue Reading

Trending